|
EXP000701
|
Development of a Novel Nanoparticle by Dual Modification With the Pluripotentia…
|
2013 |
R8/PF6-NP
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000702
|
Development of a Novel Nanoparticle by Dual Modification With the Pluripotentia…
|
2013 |
PF6/R8-NP
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000703
|
Development of a Novel Nanoparticle by Dual Modification With the Pluripotentia…
|
2013 |
R8/R8-NP
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000704
|
Development of a Novel Nanoparticle by Dual Modification With the Pluripotentia…
|
2013 |
PF6 polyplex
|
siRNA
|
no |
no |
|
no |
no |
|
EXP000705
|
Development of a Novel Nanoparticle by Dual Modification With the Pluripotentia…
|
2013 |
R8 polyplex
|
siRNA
|
no |
no |
|
no |
no |
|
EXP000706
|
Influence of lysine residue in amphipathic helical peptides on targeted deliver…
|
2019 |
PI
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000707
|
Influence of lysine residue in amphipathic helical peptides on targeted deliver…
|
2019 |
PII
|
siRNA
|
no |
no |
|
no |
no |
|
EXP000708
|
Influence of lysine residue in amphipathic helical peptides on targeted deliver…
|
2019 |
PIII
|
siRNA
|
no |
no |
|
no |
no |
|
EXP000709
|
Influence of lysine residue in amphipathic helical peptides on targeted deliver…
|
2019 |
PIV
|
siRNA
|
no |
no |
|
no |
no |
|
EXP000710
|
Influence of lysine residue in amphipathic helical peptides on targeted deliver…
|
2019 |
PV
|
siRNA
|
no |
no |
|
no |
no |
|
EXP000711
|
Perfluoroalkyl Chain-Modified Artificial Viral Capsid for Enhanced Intracellula…
|
2025 |
β-annulus-PFA
|
mRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000712
|
Perfluoroalkyl Chain-Modified Artificial Viral Capsid for Enhanced Intracellula…
|
2025 |
dT20-SS-β-annulus
|
mRNA
|
no |
no |
|
no |
no |
|
EXP000713
|
Perfluoroalkyl Chain-Modified Artificial Viral Capsid for Enhanced Intracellula…
|
2025 |
β-annulus (unmodified)
|
mRNA
|
no |
no |
|
no |
no |
|
EXP000714
|
Elucidating cell-penetrating peptide mechanisms of action for membrane interact…
|
2009 |
R9
|
SCO
|
yes |
yes |
yes |
no |
no |
|
EXP000715
|
Elucidating cell-penetrating peptide mechanisms of action for membrane interact…
|
2009 |
pTat48-60
|
SCO
|
yes |
no |
|
no |
no |
|
EXP000716
|
Elucidating cell-penetrating peptide mechanisms of action for membrane interact…
|
2009 |
Pen
|
SCO
|
yes |
no |
|
no |
no |
|
EXP000717
|
Elucidating cell-penetrating peptide mechanisms of action for membrane interact…
|
2009 |
PenArg
|
SCO
|
yes |
no |
|
no |
no |
|
EXP000718
|
Elucidating cell-penetrating peptide mechanisms of action for membrane interact…
|
2009 |
pVEC
|
SCO
|
yes |
no |
|
no |
no |
|
EXP000719
|
Elucidating cell-penetrating peptide mechanisms of action for membrane interact…
|
2009 |
M918
|
SCO
|
yes |
no |
|
no |
no |
|
EXP000720
|
Elucidating cell-penetrating peptide mechanisms of action for membrane interact…
|
2009 |
TP10
|
SCO
|
yes |
no |
|
no |
no |
|
EXP000721
|
Structural effects of oligomerization of arginine-rich peptides on cellular upt…
|
2016 |
B-mR9 polyplex
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000722
|
Structural effects of oligomerization of arginine-rich peptides on cellular upt…
|
2016 |
B-mR9 polyplex
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP000723
|
An intracellular delivery method for siRNA by an arginine-rich peptide
|
2007 |
SR9 (synthetic nona-arginine; R9)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000724
|
Polymer nanoparticles modified with photo- and pH-dual-responsive polypeptides …
|
2016 |
PPP (activated)
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000725
|
Polymer nanoparticles modified with photo- and pH-dual-responsive polypeptides …
|
2016 |
PPP (non-activated)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000726
|
Polymer nanoparticles modified with photo- and pH-dual-responsive polypeptides …
|
2016 |
CPP
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000727
|
Polymer nanoparticles modified with photo- and pH-dual-responsive polypeptides …
|
2016 |
PPP (activated)
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP000728
|
Polymer nanoparticles modified with photo- and pH-dual-responsive polypeptides …
|
2016 |
PPP (non-activated)
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP000729
|
Polymer nanoparticles modified with photo- and pH-dual-responsive polypeptides …
|
2016 |
CPP
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP000730
|
Polyethylene glycol and octaarginine dual-functionalized nano-graphene oxide: A…
|
2018 |
Octaarginine (R8)
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000731
|
Polyethylene glycol and octaarginine dual-functionalized nano-graphene oxide: A…
|
2018 |
Octaarginine (R8)
|
pDNA
|
yes |
yes |
yes |
no |
no |
|
EXP000732
|
Modification of a Designed Amphipathic Cell Penetrating Peptide and Its Effect …
|
2013 |
C6
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000733
|
Modification of a Designed Amphipathic Cell Penetrating Peptide and Its Effect …
|
2013 |
C6
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000734
|
Modification of a Designed Amphipathic Cell Penetrating Peptide and Its Effect …
|
2013 |
C6M1
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000735
|
Modification of a Designed Amphipathic Cell Penetrating Peptide and Its Effect …
|
2013 |
C6M1
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000736
|
The six amino acid antimicrobial peptide bLFcin6 penetrates cells and delivers …
|
2013 |
bLFcin6
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000737
|
The six amino acid antimicrobial peptide bLFcin6 penetrates cells and delivers …
|
2013 |
CPP5
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000738
|
The six amino acid antimicrobial peptide bLFcin6 penetrates cells and delivers …
|
2013 |
TAT
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000739
|
The six amino acid antimicrobial peptide bLFcin6 penetrates cells and delivers …
|
2013 |
CPP6
|
siRNA
|
no |
no |
|
no |
no |
|
EXP000740
|
Amphiphilic lipopeptide significantly enhances uptake of charge-neutral splice …
|
2017 |
ApoE (CPP fragment)
|
SCO
|
no |
yes |
|
no |
no |
|
EXP000741
|
Amphiphilic lipopeptide significantly enhances uptake of charge-neutral splice …
|
2017 |
Myr-ApoE (peptide amphiphile)
|
SCO
|
no |
yes |
|
no |
no |
|
EXP000742
|
Amphiphilic lipopeptide significantly enhances uptake of charge-neutral splice …
|
2017 |
ApoE (CPP fragment)
|
SCO
|
no |
yes |
|
no |
no |
|
EXP000743
|
Amphiphilic lipopeptide significantly enhances uptake of charge-neutral splice …
|
2017 |
Myr-ApoE (peptide amphiphile)
|
SCO
|
no |
yes |
|
no |
no |
|
EXP000744
|
Photolabile-caged peptide-conjugated liposomes for siRNA delivery
|
2015 |
CPP
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000745
|
Photolabile-caged peptide-conjugated liposomes for siRNA delivery
|
2015 |
PCP (caged CPP)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000746
|
Photolabile-caged peptide-conjugated liposomes for siRNA delivery
|
2015 |
PCP (NIR-uncaged)
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000747
|
Photolabile-caged peptide-conjugated liposomes for siRNA delivery
|
2015 |
PCP (NIR-uncaged)
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000748
|
Photolabile-caged peptide-conjugated liposomes for siRNA delivery
|
2015 |
CPP
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP000749
|
Photolabile-caged peptide-conjugated liposomes for siRNA delivery
|
2015 |
PCP (NIR-uncaged)
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP000750
|
Photolabile-caged peptide-conjugated liposomes for siRNA delivery
|
2015 |
PCP (caged CPP)
|
siRNA
|
yes |
|
|
yes |
yes |
|
EXP000751
|
Photolabile-caged peptide-conjugated liposomes for siRNA delivery
|
2015 |
PCP (NIR-uncaged)
|
siRNA
|
yes |
|
|
yes |
no |
|
EXP000752
|
Targeting IgE polyadenylation signal with antisense oligonucleotides decreases …
|
2022 |
Pip6a
|
ASO
|
no |
yes |
|
no |
no |
|
EXP000753
|
Targeting IgE polyadenylation signal with antisense oligonucleotides decreases …
|
2022 |
Pip6a
|
ASO
|
no |
|
|
yes |
yes |
|
EXP000754
|
Structure-activity relationship study of Aib-containing amphipathic helical pep…
|
2017 |
PI
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000755
|
Structure-activity relationship study of Aib-containing amphipathic helical pep…
|
2017 |
PII
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000756
|
Structure-activity relationship study of Aib-containing amphipathic helical pep…
|
2017 |
PIII
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000757
|
Structure-activity relationship study of Aib-containing amphipathic helical pep…
|
2017 |
PIV
|
siRNA
|
no |
no |
|
no |
no |
|
EXP000758
|
Structure-activity relationship study of Aib-containing amphipathic helical pep…
|
2017 |
PV
|
siRNA
|
no |
no |
|
no |
no |
|
EXP000759
|
Structure-activity relationship study of Aib-containing amphipathic helical pep…
|
2017 |
PVI
|
siRNA
|
no |
no |
|
no |
no |
|
EXP000760
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4
|
mRNA
|
no |
yes |
yes |
no |
no |
|
EXP000761
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-L0
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000762
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-L1
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000763
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-L2
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000764
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-L3
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000765
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-L4
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000766
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-L5
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000767
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-L6
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000768
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-A1
|
mRNA
|
no |
yes |
yes |
no |
no |
|
EXP000769
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-A2
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000770
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-A3
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000771
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-A4
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000772
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-A5
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000773
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-A6
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000774
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-A1-Trp2
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000775
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-A1-Tyr2
|
mRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000776
|
N-terminal modification of an LAH4-derived peptide increases mRNA delivery in t…
|
2024 |
LAH4-A1-Sali
|
mRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000777
|
Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovaria…
|
2023 |
MLP1
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP000778
|
Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovaria…
|
2023 |
MLP2
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000779
|
Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovaria…
|
2023 |
MLP3
|
siRNA
|
no |
no |
|
no |
no |
|
EXP000780
|
Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovaria…
|
2023 |
MLP4
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000781
|
Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovaria…
|
2023 |
MLP5
|
siRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000782
|
Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovaria…
|
2023 |
MLP6
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000783
|
Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovaria…
|
2023 |
MLP4
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP000784
|
MicroRNA delivery by arginine-rich cell-penetrating peptides: An investigation …
|
2024 |
MR
|
miRNA
|
yes |
yes |
|
no |
no |
|
EXP000785
|
MicroRNA delivery by arginine-rich cell-penetrating peptides: An investigation …
|
2024 |
R9
|
miRNA
|
yes |
yes |
|
no |
no |
|
EXP000786
|
Induction of splice correction by cell-penetrating peptide nucleic acids
|
2006 |
Tat
|
SCO
|
yes |
yes |
yes |
no |
no |
|
EXP000787
|
Induction of splice correction by cell-penetrating peptide nucleic acids
|
2006 |
Penetratin
|
SCO
|
yes |
yes |
yes |
no |
no |
|
EXP000788
|
Induction of splice correction by cell-penetrating peptide nucleic acids
|
2006 |
Transportan
|
SCO
|
yes |
yes |
yes |
no |
no |
|
EXP000789
|
Induction of splice correction by cell-penetrating peptide nucleic acids
|
2006 |
Tat
|
SCO
|
yes |
no |
yes |
no |
no |
|
EXP000790
|
Induction of splice correction by cell-penetrating peptide nucleic acids
|
2006 |
Penetratin
|
SCO
|
yes |
no |
yes |
no |
no |
|
EXP000791
|
Induction of splice correction by cell-penetrating peptide nucleic acids
|
2006 |
Transportan
|
SCO
|
yes |
no |
yes |
no |
no |
|
EXP000792
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
KALA
|
mRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000793
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
R8
|
mRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000794
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
KALA
|
mRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000795
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
KALA
|
mRNA
|
yes |
yes |
yes |
no |
no |
|
EXP000796
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
KALA
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000797
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
R8
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000798
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
KALA
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000799
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
KALA
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP000800
|
Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with…
|
2019 |
KALA
|
mRNA
|
no |
|
|
yes |
yes |